Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial

  • Sarit Assouline
  • , Valeria Buccheri
  • , Alain Delmer
  • , Gianluca Gaidano
  • , Marek Trneny
  • , Natalia Berthillon
  • , Michael Brewster
  • , Olivier Catalani
  • , Sai Li
  • , Christine McIntyre
  • , Pakeeza Sayyed
  • , Xavier Badoux

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Fingerprint

Entra nei temi di ricerca di 'Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial'. Insieme formano una fingerprint unica.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science